10 Best Newsletters to Prevent Brain Rot in 2025

Weekly

AI Lab

Explores AI's role in robotics, with spotlights on humanoid breakthroughs (e.g., single-model training for movements) and broader implications like workforce integration. Includes reader Q&A on robot 'breakthroughs.'

WIRED

AI

Robotics & Automation

Tech Trends

Daily/Weekly

The Robot Report Newsletter

Daily/weekly robotics news digest, heavy on humanoid updates from global players, including Chinese firms like Unitree, with analysis on hardware, software, and events like CES or UFC demos.

The Robot Report

Robotics & Automation

AI

Business & Startups

Weekly

Transformers

AI and robotics-focused, covering humanoid 'revolutions' from bartenders to surgical aides, with exclusive interviews and trends like Tesla's Optimus scaling.

VentureBeat

AI

Robotics & Automation

Business & Startups

Monthly

Code to Cure

A newsletter co-hosted by the Wyss Institute at Harvard University, focusing on the intersection of AI, biology, and healthcare to transform medicine, with emphasis on AI-driven drug discovery and accelerating life-saving therapies.

Wyss Institute at Harvard & Milad Alucozai

AI

Biotechnology & Medicine

Longevity Escape Velocity

Daily

Future Pulse

Daily insights into health care innovations, including AI's role in drug discovery, repurposing existing drugs for rare diseases, and accelerating treatments for conditions like idiopathic pulmonary fibrosis and ALS.

POLITICO

AI

Longevity Escape Velocity

Biotechnology & Medicine

Weekly

Nature Briefing: Translational Research

Top stories in biotechnology, drug discovery, and pharma, highlighting AI-enabled milestones like clinical trials for AI-discovered drugs targeting idiopathic pulmonary fibrosis and regulatory challenges in AI therapeutics.

Nature Medicine

AI

Biotechnology & Medicine

Clinical Trials

Daily

AI in Healthcare News

Breaking news and breakthroughs on AI applications in healthcare, covering precision medicine, AI-discovered drugs for cancer and neurological disorders, and accelerated timelines in psychiatric drug design.

Crescendo.ai

AI

Longevity Escape Velocity

Biotechnology & Medicine

Annual

PP405 Molecule: Stem Cell Reactivator for Pattern Baldness

UCLA researchers developed PP405, a topical molecule that inhibits the SCUBE3 protein to 'wake up' dormant hair follicle stem cells, promoting regrowth. Phase 1 trials showed safety and follicle activation in humans within a week; Phase 3 starts in 2026. Effective in mice for full reversal, with potential to regrow hair on scarred scalps.

UCLA Broad Stem Cell Research Center & Pelage Pharmaceuticals

Longevity Escape Velocity

Clinical Trials